NCT06674330View on ClinicalTrials.gov

Using a Population Pharmacokinetic Model to Estimate the Dosage of Teicoplanin in Patients With Hematologic Malignancy or Critical Illness

Not yet recruitingOBSERVATIONAL

Enrollment

600

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

September 30, 2025

Study Completion Date

December 31, 2025

Conditions

Hematological MalignanciesCritical Illness

Interventions

OTHER

concentration of teicoplanin

post analysis of concentration of teicoplanin

All Listed Sponsors

lead

National Taiwan University Hospital

OTHER